𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Extracorporeal albumin dialysis in acute-on-chronic liver failure: Will it stand the test of time?

✍ Scribed by Sen, S

Book ID
123232136
Publisher
John Wiley and Sons
Year
2002
Tongue
English
Weight
59 KB
Volume
36
Category
Article
ISSN
0270-9139

No coin nor oath required. For personal study only.

πŸ“œ SIMILAR VOLUMES

Extracorporeal albumin dialysis with the
Extracorporeal albumin dialysis with the molecular adsorbent recirculating system in acute-on-chronic liver failure: The RELIEF trial
✍ BaΓ±ares, Rafael; Nevens, Frederik; Larsen, Fin Stolze; Jalan, Rajiv; Albillos, A πŸ“‚ Article πŸ“… 2013 πŸ› John Wiley and Sons 🌐 English βš– 527 KB

Acute-on-chronic liver failure (ACLF) is a frequent cause of death in cirrhosis. Albumin dialysis with the molecular adsorbent recirculating system (MARS) decreases retained substances and improves hemodynamics and hepatic encephalopathy (HE). However, its survival impact is unknown. In all, 189 pat

Improvement of impaired albumin binding
Improvement of impaired albumin binding capacity in acute-on-chronic liver failure by albumin dialysis
✍ Sebastian Klammt; Steffen R. Mitzner; Jan Stange; Jan Loock; Uwe Heemann; JΓΆrg E πŸ“‚ Article πŸ“… 2008 πŸ› John Wiley and Sons 🌐 English βš– 239 KB

Extracorporeal albumin dialysis (ECAD) enables the elimination of albumin bound substances and is used as artificial liver support system. Albumin binding function for the benzodiazepine binding site specific marker Dansylsarcosine was estimated in plasma samples of 22 patients with cirrhosis and hy